Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Lymphoma, Follicular 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

gallium 68 PSMA-11 1fluciclovine F-18 1Radiosurgery 1Proton Therapy 1Magnetic Resonance Spectroscopy 168Ga-DKFZ-PSMA-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Prostate Adenocarcinoma × fluciclovine F-18 × Clear all
NCT03762759 2024-05-17

Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Emory University

Phase 2 Unknown
140 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡